EV Biologics (EV Biologics) Price-to-Operating-Cash-Flow : (As of May. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Price-to-Operating-Cash-Flow?

As of today (2024-05-21), EV Biologics's share price is $0.5541. EV Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2017 was $-10.24. Hence, EV Biologics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for EV Biologics's Price-to-Operating-Cash-Flow or its related term are showing as below:

YECO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.93
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

EV Biologics's Cash Flow from Operations per share for the three months ended in Dec. 2017 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2017 was $-10.24.

EV Biologics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for EV Biologics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Price-to-Operating-Cash-Flow Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Price-to-Operating-Cash-Flow

10.31

1.54

3.95

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial												1.54	2.64	-	-	-

Competitive Comparison of EV Biologics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, EV Biologics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where EV Biologics's Price-to-Operating-Cash-Flow falls into.

EV Biologics Price-to-Operating-Cash-Flow Calculation

EV Biologics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.5541	/	-10.236
	=

EV Biologics's Share Price of today is $0.5541.
EV Biologics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.24.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

EV Biologics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of EV Biologics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3